Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: Involvement of the monoaminergic system
Rosemary, Rosmarinus officinalis L. (Labiatae) has several therapeutic applications in folk medicine in curing or managing a wide range of diseases, including depression. In this study, the effect of the hydroalcoholic extract of the stems and leaves of this plant was investigated in two behavioral...
Gespeichert in:
Veröffentlicht in: | Progress in neuro-psychopharmacology & biological psychiatry 2009-06, Vol.33 (4), p.642-650 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 650 |
---|---|
container_issue | 4 |
container_start_page | 642 |
container_title | Progress in neuro-psychopharmacology & biological psychiatry |
container_volume | 33 |
creator | Machado, Daniele G. Bettio, Luis E.B. Cunha, Mauricio P. Capra, Juliano C. Dalmarco, Juliana B. Pizzolatti, Moacir G. Rodrigues, Ana Lúcia S. |
description | Rosemary,
Rosmarinus officinalis L. (Labiatae) has several therapeutic applications in folk medicine in curing or managing a wide range of diseases, including depression. In this study, the effect of the hydroalcoholic extract of the stems and leaves of this plant was investigated in two behavioral models, the forced swimming test (FST) and tail suspension test (TST) in mice. The extract of
R. officinalis produced an antidepressant-like effect, since the acute treatment of mice with the extract by p.o. route significantly reduced the immobility time in the FST (100 mg/kg) and TST (10–100 mg/kg), as compared to a control group, without accompanying changes in ambulation in the open-field test. Moreover, the repeated administration (14 days) of the hydroalcoholic extract of
R. officinalis by p.o. route also produced an antidepressant-like effect in the TST (100–300 mg/kg). The pretreatment of mice with p-chlorophenylalanine (PCPA, 100 mg/kg, i.p., an inhibitor of serotonin synthesis, for 4 consecutive days), NAN-190 (0.5 mg/kg, i.p., a 5-HT
1A receptor antagonist), ketanserin (5 mg/kg, i.p., a 5-HT
2A receptor antagonist), 1-(m-chlorophenyl) biguanide (mCPBG, 10 mg/kg, i.p., a 5-HT
3 receptor agonist), prazosin (1 mg/kg, i.p., an α
1-adrenoceptor antagonist), SCH23390 (0.05 mg/kg, s.c., a dopamine D
1 receptor antagonist) or sulpiride (50 mg/kg, i.p., a dopamine D
2 receptor antagonist), but not yohimbine (1 mg/kg, i.p., an α
2-adrenoceptor antagonist) was able to reverse the anti-immobility effect of the extract (10 mg/kg, p.o.) in the TST. The combination of MDL72222, (0.1 mg/kg, i.p., a 5-HT
3 receptor antagonist) with a sub-effective dose of the extract of
R. officinalis (1 mg/kg, p.o.) produced an anti-immobility effect in the TST. The results suggest that the antidepressant action of the extract of
R. officinalis is mediated by an interaction with the monoaminergic system and that this plant should be further investigated as an alternative therapeutic approach for the treatment of depression. |
doi_str_mv | 10.1016/j.pnpbp.2009.03.004 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67210424</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0278584609000633</els_id><sourcerecordid>67210424</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-cbd02c080d294dc893d7a9ac560ea868fd8dbcf62dde3e4e74fdfb2b740797a73</originalsourceid><addsrcrecordid>eNqFkdFqFDEUhoModq0-gSBzo3czPclkZjKCF6W0WigIotchk5xo1plkTLKLfXuz7lLv7FVy4PtPwv8R8ppCQ4H2F9tm9eu0NgxgbKBtAPgTsqFiEDVntH9KNsDKvRO8PyMvUtoCAG2hfU7O6MhEz3m_IfnSZ2dwjZiS8rme3U-s0FrUuQq2yj_K9DtHdRy_hLSo6Pwulck67byaXaqcrxan8X116_dh3uOC_iG9BB_U4jzG705X6T5lXF6SZ1bNCV-dznPy7eb669Wn-u7zx9ury7tac8FzrScDTIMAw0ZutBhbM6hR6a4HVKIX1ggzadszY7BFjgO3xk5sGjgM46CG9py8O-5dY_i1w5Tl4pLGeVYewy7JfmAUOOOPggy6kZXSCtgeQR1DShGtXKMrldxLCvJgRW7lXyvyYEVCK4uVknpzWr-bFjT_MicNBXh7AlTSarZRee3SA8do1wHjh-c_HDksre0dRpm0Q6_RuFiMSRPcfz_yB6eBrs8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20592192</pqid></control><display><type>article</type><title>Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: Involvement of the monoaminergic system</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Machado, Daniele G. ; Bettio, Luis E.B. ; Cunha, Mauricio P. ; Capra, Juliano C. ; Dalmarco, Juliana B. ; Pizzolatti, Moacir G. ; Rodrigues, Ana Lúcia S.</creator><creatorcontrib>Machado, Daniele G. ; Bettio, Luis E.B. ; Cunha, Mauricio P. ; Capra, Juliano C. ; Dalmarco, Juliana B. ; Pizzolatti, Moacir G. ; Rodrigues, Ana Lúcia S.</creatorcontrib><description>Rosemary,
Rosmarinus officinalis L. (Labiatae) has several therapeutic applications in folk medicine in curing or managing a wide range of diseases, including depression. In this study, the effect of the hydroalcoholic extract of the stems and leaves of this plant was investigated in two behavioral models, the forced swimming test (FST) and tail suspension test (TST) in mice. The extract of
R. officinalis produced an antidepressant-like effect, since the acute treatment of mice with the extract by p.o. route significantly reduced the immobility time in the FST (100 mg/kg) and TST (10–100 mg/kg), as compared to a control group, without accompanying changes in ambulation in the open-field test. Moreover, the repeated administration (14 days) of the hydroalcoholic extract of
R. officinalis by p.o. route also produced an antidepressant-like effect in the TST (100–300 mg/kg). The pretreatment of mice with p-chlorophenylalanine (PCPA, 100 mg/kg, i.p., an inhibitor of serotonin synthesis, for 4 consecutive days), NAN-190 (0.5 mg/kg, i.p., a 5-HT
1A receptor antagonist), ketanserin (5 mg/kg, i.p., a 5-HT
2A receptor antagonist), 1-(m-chlorophenyl) biguanide (mCPBG, 10 mg/kg, i.p., a 5-HT
3 receptor agonist), prazosin (1 mg/kg, i.p., an α
1-adrenoceptor antagonist), SCH23390 (0.05 mg/kg, s.c., a dopamine D
1 receptor antagonist) or sulpiride (50 mg/kg, i.p., a dopamine D
2 receptor antagonist), but not yohimbine (1 mg/kg, i.p., an α
2-adrenoceptor antagonist) was able to reverse the anti-immobility effect of the extract (10 mg/kg, p.o.) in the TST. The combination of MDL72222, (0.1 mg/kg, i.p., a 5-HT
3 receptor antagonist) with a sub-effective dose of the extract of
R. officinalis (1 mg/kg, p.o.) produced an anti-immobility effect in the TST. The results suggest that the antidepressant action of the extract of
R. officinalis is mediated by an interaction with the monoaminergic system and that this plant should be further investigated as an alternative therapeutic approach for the treatment of depression.</description><identifier>ISSN: 0278-5846</identifier><identifier>EISSN: 1878-4216</identifier><identifier>DOI: 10.1016/j.pnpbp.2009.03.004</identifier><identifier>PMID: 19286446</identifier><identifier>CODEN: PNPPD7</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>Adrenergic alpha-Antagonists - pharmacology ; Adult and adolescent clinical studies ; Analysis of Variance ; Animals ; Antidepressive Agents - pharmacology ; Antidepressive Agents - therapeutic use ; Behavior, Animal - drug effects ; Benzazepines - pharmacology ; Biogenic Monoamines - metabolism ; Biological and medical sciences ; Depression ; Depression - drug therapy ; Disease Models, Animal ; Dopamine ; Dopamine Antagonists - pharmacology ; Exploratory Behavior - drug effects ; Forced swimming test ; Hindlimb Suspension - methods ; Immobility Response, Tonic - drug effects ; Male ; Medical sciences ; Mice ; Mood disorders ; Neuropharmacology ; Noradrenaline ; Pharmacology. Drug treatments ; Phytotherapy ; Plant Extracts - pharmacology ; Prazosin - pharmacology ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychopharmacology ; Rosmarinus - chemistry ; Rosmarinus officinalis ; Serotonin ; Serotonin Agents - pharmacology ; Swimming ; Tail suspension test ; Time Factors</subject><ispartof>Progress in neuro-psychopharmacology & biological psychiatry, 2009-06, Vol.33 (4), p.642-650</ispartof><rights>2009 Elsevier Inc.</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c484t-cbd02c080d294dc893d7a9ac560ea868fd8dbcf62dde3e4e74fdfb2b740797a73</citedby><cites>FETCH-LOGICAL-c484t-cbd02c080d294dc893d7a9ac560ea868fd8dbcf62dde3e4e74fdfb2b740797a73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.pnpbp.2009.03.004$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21550242$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19286446$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Machado, Daniele G.</creatorcontrib><creatorcontrib>Bettio, Luis E.B.</creatorcontrib><creatorcontrib>Cunha, Mauricio P.</creatorcontrib><creatorcontrib>Capra, Juliano C.</creatorcontrib><creatorcontrib>Dalmarco, Juliana B.</creatorcontrib><creatorcontrib>Pizzolatti, Moacir G.</creatorcontrib><creatorcontrib>Rodrigues, Ana Lúcia S.</creatorcontrib><title>Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: Involvement of the monoaminergic system</title><title>Progress in neuro-psychopharmacology & biological psychiatry</title><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><description>Rosemary,
Rosmarinus officinalis L. (Labiatae) has several therapeutic applications in folk medicine in curing or managing a wide range of diseases, including depression. In this study, the effect of the hydroalcoholic extract of the stems and leaves of this plant was investigated in two behavioral models, the forced swimming test (FST) and tail suspension test (TST) in mice. The extract of
R. officinalis produced an antidepressant-like effect, since the acute treatment of mice with the extract by p.o. route significantly reduced the immobility time in the FST (100 mg/kg) and TST (10–100 mg/kg), as compared to a control group, without accompanying changes in ambulation in the open-field test. Moreover, the repeated administration (14 days) of the hydroalcoholic extract of
R. officinalis by p.o. route also produced an antidepressant-like effect in the TST (100–300 mg/kg). The pretreatment of mice with p-chlorophenylalanine (PCPA, 100 mg/kg, i.p., an inhibitor of serotonin synthesis, for 4 consecutive days), NAN-190 (0.5 mg/kg, i.p., a 5-HT
1A receptor antagonist), ketanserin (5 mg/kg, i.p., a 5-HT
2A receptor antagonist), 1-(m-chlorophenyl) biguanide (mCPBG, 10 mg/kg, i.p., a 5-HT
3 receptor agonist), prazosin (1 mg/kg, i.p., an α
1-adrenoceptor antagonist), SCH23390 (0.05 mg/kg, s.c., a dopamine D
1 receptor antagonist) or sulpiride (50 mg/kg, i.p., a dopamine D
2 receptor antagonist), but not yohimbine (1 mg/kg, i.p., an α
2-adrenoceptor antagonist) was able to reverse the anti-immobility effect of the extract (10 mg/kg, p.o.) in the TST. The combination of MDL72222, (0.1 mg/kg, i.p., a 5-HT
3 receptor antagonist) with a sub-effective dose of the extract of
R. officinalis (1 mg/kg, p.o.) produced an anti-immobility effect in the TST. The results suggest that the antidepressant action of the extract of
R. officinalis is mediated by an interaction with the monoaminergic system and that this plant should be further investigated as an alternative therapeutic approach for the treatment of depression.</description><subject>Adrenergic alpha-Antagonists - pharmacology</subject><subject>Adult and adolescent clinical studies</subject><subject>Analysis of Variance</subject><subject>Animals</subject><subject>Antidepressive Agents - pharmacology</subject><subject>Antidepressive Agents - therapeutic use</subject><subject>Behavior, Animal - drug effects</subject><subject>Benzazepines - pharmacology</subject><subject>Biogenic Monoamines - metabolism</subject><subject>Biological and medical sciences</subject><subject>Depression</subject><subject>Depression - drug therapy</subject><subject>Disease Models, Animal</subject><subject>Dopamine</subject><subject>Dopamine Antagonists - pharmacology</subject><subject>Exploratory Behavior - drug effects</subject><subject>Forced swimming test</subject><subject>Hindlimb Suspension - methods</subject><subject>Immobility Response, Tonic - drug effects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mood disorders</subject><subject>Neuropharmacology</subject><subject>Noradrenaline</subject><subject>Pharmacology. Drug treatments</subject><subject>Phytotherapy</subject><subject>Plant Extracts - pharmacology</subject><subject>Prazosin - pharmacology</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Rosmarinus - chemistry</subject><subject>Rosmarinus officinalis</subject><subject>Serotonin</subject><subject>Serotonin Agents - pharmacology</subject><subject>Swimming</subject><subject>Tail suspension test</subject><subject>Time Factors</subject><issn>0278-5846</issn><issn>1878-4216</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkdFqFDEUhoModq0-gSBzo3czPclkZjKCF6W0WigIotchk5xo1plkTLKLfXuz7lLv7FVy4PtPwv8R8ppCQ4H2F9tm9eu0NgxgbKBtAPgTsqFiEDVntH9KNsDKvRO8PyMvUtoCAG2hfU7O6MhEz3m_IfnSZ2dwjZiS8rme3U-s0FrUuQq2yj_K9DtHdRy_hLSo6Pwulck67byaXaqcrxan8X116_dh3uOC_iG9BB_U4jzG705X6T5lXF6SZ1bNCV-dznPy7eb669Wn-u7zx9ury7tac8FzrScDTIMAw0ZutBhbM6hR6a4HVKIX1ggzadszY7BFjgO3xk5sGjgM46CG9py8O-5dY_i1w5Tl4pLGeVYewy7JfmAUOOOPggy6kZXSCtgeQR1DShGtXKMrldxLCvJgRW7lXyvyYEVCK4uVknpzWr-bFjT_MicNBXh7AlTSarZRee3SA8do1wHjh-c_HDksre0dRpm0Q6_RuFiMSRPcfz_yB6eBrs8</recordid><startdate>20090615</startdate><enddate>20090615</enddate><creator>Machado, Daniele G.</creator><creator>Bettio, Luis E.B.</creator><creator>Cunha, Mauricio P.</creator><creator>Capra, Juliano C.</creator><creator>Dalmarco, Juliana B.</creator><creator>Pizzolatti, Moacir G.</creator><creator>Rodrigues, Ana Lúcia S.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>20090615</creationdate><title>Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: Involvement of the monoaminergic system</title><author>Machado, Daniele G. ; Bettio, Luis E.B. ; Cunha, Mauricio P. ; Capra, Juliano C. ; Dalmarco, Juliana B. ; Pizzolatti, Moacir G. ; Rodrigues, Ana Lúcia S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-cbd02c080d294dc893d7a9ac560ea868fd8dbcf62dde3e4e74fdfb2b740797a73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adrenergic alpha-Antagonists - pharmacology</topic><topic>Adult and adolescent clinical studies</topic><topic>Analysis of Variance</topic><topic>Animals</topic><topic>Antidepressive Agents - pharmacology</topic><topic>Antidepressive Agents - therapeutic use</topic><topic>Behavior, Animal - drug effects</topic><topic>Benzazepines - pharmacology</topic><topic>Biogenic Monoamines - metabolism</topic><topic>Biological and medical sciences</topic><topic>Depression</topic><topic>Depression - drug therapy</topic><topic>Disease Models, Animal</topic><topic>Dopamine</topic><topic>Dopamine Antagonists - pharmacology</topic><topic>Exploratory Behavior - drug effects</topic><topic>Forced swimming test</topic><topic>Hindlimb Suspension - methods</topic><topic>Immobility Response, Tonic - drug effects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mood disorders</topic><topic>Neuropharmacology</topic><topic>Noradrenaline</topic><topic>Pharmacology. Drug treatments</topic><topic>Phytotherapy</topic><topic>Plant Extracts - pharmacology</topic><topic>Prazosin - pharmacology</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Rosmarinus - chemistry</topic><topic>Rosmarinus officinalis</topic><topic>Serotonin</topic><topic>Serotonin Agents - pharmacology</topic><topic>Swimming</topic><topic>Tail suspension test</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Machado, Daniele G.</creatorcontrib><creatorcontrib>Bettio, Luis E.B.</creatorcontrib><creatorcontrib>Cunha, Mauricio P.</creatorcontrib><creatorcontrib>Capra, Juliano C.</creatorcontrib><creatorcontrib>Dalmarco, Juliana B.</creatorcontrib><creatorcontrib>Pizzolatti, Moacir G.</creatorcontrib><creatorcontrib>Rodrigues, Ana Lúcia S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Progress in neuro-psychopharmacology & biological psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Machado, Daniele G.</au><au>Bettio, Luis E.B.</au><au>Cunha, Mauricio P.</au><au>Capra, Juliano C.</au><au>Dalmarco, Juliana B.</au><au>Pizzolatti, Moacir G.</au><au>Rodrigues, Ana Lúcia S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: Involvement of the monoaminergic system</atitle><jtitle>Progress in neuro-psychopharmacology & biological psychiatry</jtitle><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><date>2009-06-15</date><risdate>2009</risdate><volume>33</volume><issue>4</issue><spage>642</spage><epage>650</epage><pages>642-650</pages><issn>0278-5846</issn><eissn>1878-4216</eissn><coden>PNPPD7</coden><abstract>Rosemary,
Rosmarinus officinalis L. (Labiatae) has several therapeutic applications in folk medicine in curing or managing a wide range of diseases, including depression. In this study, the effect of the hydroalcoholic extract of the stems and leaves of this plant was investigated in two behavioral models, the forced swimming test (FST) and tail suspension test (TST) in mice. The extract of
R. officinalis produced an antidepressant-like effect, since the acute treatment of mice with the extract by p.o. route significantly reduced the immobility time in the FST (100 mg/kg) and TST (10–100 mg/kg), as compared to a control group, without accompanying changes in ambulation in the open-field test. Moreover, the repeated administration (14 days) of the hydroalcoholic extract of
R. officinalis by p.o. route also produced an antidepressant-like effect in the TST (100–300 mg/kg). The pretreatment of mice with p-chlorophenylalanine (PCPA, 100 mg/kg, i.p., an inhibitor of serotonin synthesis, for 4 consecutive days), NAN-190 (0.5 mg/kg, i.p., a 5-HT
1A receptor antagonist), ketanserin (5 mg/kg, i.p., a 5-HT
2A receptor antagonist), 1-(m-chlorophenyl) biguanide (mCPBG, 10 mg/kg, i.p., a 5-HT
3 receptor agonist), prazosin (1 mg/kg, i.p., an α
1-adrenoceptor antagonist), SCH23390 (0.05 mg/kg, s.c., a dopamine D
1 receptor antagonist) or sulpiride (50 mg/kg, i.p., a dopamine D
2 receptor antagonist), but not yohimbine (1 mg/kg, i.p., an α
2-adrenoceptor antagonist) was able to reverse the anti-immobility effect of the extract (10 mg/kg, p.o.) in the TST. The combination of MDL72222, (0.1 mg/kg, i.p., a 5-HT
3 receptor antagonist) with a sub-effective dose of the extract of
R. officinalis (1 mg/kg, p.o.) produced an anti-immobility effect in the TST. The results suggest that the antidepressant action of the extract of
R. officinalis is mediated by an interaction with the monoaminergic system and that this plant should be further investigated as an alternative therapeutic approach for the treatment of depression.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>19286446</pmid><doi>10.1016/j.pnpbp.2009.03.004</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0278-5846 |
ispartof | Progress in neuro-psychopharmacology & biological psychiatry, 2009-06, Vol.33 (4), p.642-650 |
issn | 0278-5846 1878-4216 |
language | eng |
recordid | cdi_proquest_miscellaneous_67210424 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Adrenergic alpha-Antagonists - pharmacology Adult and adolescent clinical studies Analysis of Variance Animals Antidepressive Agents - pharmacology Antidepressive Agents - therapeutic use Behavior, Animal - drug effects Benzazepines - pharmacology Biogenic Monoamines - metabolism Biological and medical sciences Depression Depression - drug therapy Disease Models, Animal Dopamine Dopamine Antagonists - pharmacology Exploratory Behavior - drug effects Forced swimming test Hindlimb Suspension - methods Immobility Response, Tonic - drug effects Male Medical sciences Mice Mood disorders Neuropharmacology Noradrenaline Pharmacology. Drug treatments Phytotherapy Plant Extracts - pharmacology Prazosin - pharmacology Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Psychopharmacology Rosmarinus - chemistry Rosmarinus officinalis Serotonin Serotonin Agents - pharmacology Swimming Tail suspension test Time Factors |
title | Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: Involvement of the monoaminergic system |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T04%3A30%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antidepressant-like%20effect%20of%20the%20extract%20of%20Rosmarinus%20officinalis%20in%20mice:%20Involvement%20of%20the%20monoaminergic%20system&rft.jtitle=Progress%20in%20neuro-psychopharmacology%20&%20biological%20psychiatry&rft.au=Machado,%20Daniele%20G.&rft.date=2009-06-15&rft.volume=33&rft.issue=4&rft.spage=642&rft.epage=650&rft.pages=642-650&rft.issn=0278-5846&rft.eissn=1878-4216&rft.coden=PNPPD7&rft_id=info:doi/10.1016/j.pnpbp.2009.03.004&rft_dat=%3Cproquest_cross%3E67210424%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20592192&rft_id=info:pmid/19286446&rft_els_id=S0278584609000633&rfr_iscdi=true |